1. Glucocorticoid dependent severe asthmatics treated with dupilumab for 24 weeks used significantly lower doses of glucocorticoids while maintaining asthmatic control compared to placebo treated patients.
2. Dupilumab treated patients experienced lower rates of severe asthma exacerbations compared to those treated with placebo.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Patients with...
May 20 - 27, 2013
In this section, we will highlight the some of the high-impact studies, updates, and analyses published in medicine during the past week.
Prone Positioning in Severe Acute Respiratory Distress Syndrome
In this multicenter RCT (n = 465), patients with moderate to severe ARDS (<150mmHg PaO2/FiO2) were shown...